Notably, the administration of anti-PD-L1 immunotherapy to mice with UPP1-inhibited tumors showed a further increase in the inhibitory effects on tumor growth, suggesting that inhibiting UPP1 expression increased the sensitivity of tumors to anti-PD-L1 immunotherapy. Here, CD274 is linked to neoplasm.